NewEdge Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $816K | Sell |
|
|||||
|
2025
Q1 | $3.01M | Buy |
|
|||||
|
2024
Q4 | $3.21M | Buy |
|
|||||
|
2024
Q3 | $3.47M | Buy |
|
|||||
|
2024
Q2 | $3.22M | Sell |
|
|||||
|
2024
Q1 | $3.5M | Buy |
|
|||||
|
2023
Q4 | $3.1M | Sell |
|
|||||
|
2023
Q3 | $2.56M | Sell |
|
|||||
|
2023
Q2 | $3.03M | Buy |
|
|||||
|
2023
Q1 | $767K | Buy |
|
|||||
|
2022
Q4 | $454K | Buy |
|
|||||
|
2022
Q3 | $285K | Buy |
|
|||||
|
2022
Q2 | $265K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $317K | Buy |
|